Bausch & Lomb Incorporated

This study tests a new eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. The goal is to see if BL1107 is safe and improves vision better than the current option. Participants will use the drops for about a month and ha…

This study tests a new type of lens (enVista Beyond) placed in the eye during cataract surgery. The goal is to see if it helps people see clearly at far, middle, and near distances without glasses. About 304 adults with cataracts are taking part. The study compares this new lens …

This study was designed to check the long-term safety of a new eye drop combination for dry eye disease over 12 months. It was planned for people who had already completed an earlier study of the same drug. However, the study was withdrawn before any participants were enrolled, s…

This early-stage study tests whether BL1332 eye drops are safe and tolerable for healthy adults aged 18 to 50. Researchers will give different strengths of the drops to 24 volunteers to find the highest safe dose. The goal is to prepare for future studies in people with eye pain.

This study is testing a new excimer laser used in LASIK surgery to safely and effectively correct farsightedness (hyperopia), with or without astigmatism. About 140 adults aged 22 and older will receive the laser treatment in one or both eyes. The main goal is to see if most pati…